Loading stock data...
b95d996a5d96c99b98d66d0a601ef9ef.cf

Zoetis to Present Q4 and Full-Year 2024 Earnings Results in Live Webcast and Conference Call

Zoetis to Host Webcast and Conference Call on February 13, 2025

On January 7, 2025, Zoetis Inc. (NYSE: ZTS), a leading animal health company, announced that it will host a webcast and conference call on Thursday, February 13, 2025, at 8:30 a.m. (ET). The event is expected to be attended by Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph.

Fourth Quarter and Full Year 2024 Financial Results Review

During the webcast and conference call, Zoetis’ executive leadership team will review the company’s fourth quarter and full year 2024 financial results. Investors and analysts are encouraged to submit questions in advance to ensure that their queries are addressed during the Q&A session.

How to Access the Webcast and Conference Call

The live webcast of the event can be accessed by visiting Zoetis’ website at http://investor.zoetis.com/events-presentations. Information on accessing and pre-registering for the webcast is available beginning today. A replay of the webcast will be made available on February 13, 2025.

About Zoetis

As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. With over 70 years of experience in predicting, preventing, detecting, and treating animal illness, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers.

Zoetis’ Leading Portfolio and Pipeline

Zoetis’ leading portfolio and pipeline of medicines, vaccines, diagnostics, and technologies make a difference in over 100 countries. The company’s innovative products and services are designed to improve animal health and well-being, while also promoting sustainable agriculture practices.

Company Overview

A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees worldwide. For more information about Zoetis, please visit <www.zoetis.com>.

Executive Leadership Team

Zoetis’ executive leadership team is comprised of experienced professionals who are committed to advancing animal care and well-being. Kristin Peck, Chief Executive Officer, has over 20 years of experience in the animal health industry, while Wetteny Joseph, Executive Vice President and Chief Financial Officer, brings a wealth of knowledge in finance and accounting.

Investor Relations Contacts

For investor-related inquiries or to submit questions for the webcast and conference call, please contact:

  • Steve Frank (973) 822-7141 (o)
  • Nick Soonthornchai (973) 443-2792 (o)

Media Relations Contacts

For media-related inquiries or to schedule an interview with a Zoetis spokesperson, please contact:

  • Jennifer Albano (862) 399-0810 (o)
  • Laura Panza (973) 975-5176 (o)

View Source Version on Businesswire.com

To view the source version of this press release, please visit https://www.businesswire.com/news/home/20250107897475/en/.

ZTS-COR ZTS-IR

Zoetis Inc. is a leading animal health company that operates in over 100 countries worldwide. The company’s mission is to nurture our world and humankind by advancing care for animals.

Company Milestones

  • Founded in 2013 as a spin-off from Pfizer Animal Health
  • Listed on the New York Stock Exchange (NYSE) in 2013 under ticker symbol ZTS
  • Generated revenue of $8.5 billion in 2023 with approximately 14,100 employees worldwide

Animal Health Industry Overview

The global animal health market is expected to grow at a CAGR of 6% from 2023 to 2030, driven by increasing demand for high-quality food and rising pet ownership rates.

Key Products and Services

Zoetis’ leading portfolio and pipeline include:

  • Medicines: Vaccines, antibiotics, and antiparasitic agents
  • Vaccines: Influenza, rabies, and distemper vaccines for companion animals
  • Diagnostics: Laboratory tests and diagnostic equipment for veterinarians and animal health professionals
  • Technologies: Digital technologies, such as artificial intelligence (AI) and data analytics, to improve animal health and well-being

Zoetis’ Sustainability Initiatives

Zoetis is committed to sustainability and has implemented various initiatives to reduce its environmental impact. These include:

  • Renewable Energy: The company has invested in renewable energy sources, such as solar and wind power
  • Water Conservation: Zoetis has implemented water conservation measures at its manufacturing facilities worldwide
  • Waste Reduction: The company has reduced waste generation by implementing recycling programs and reducing packaging material

Zoetis’ Community Engagement

Zoetis is committed to giving back to the community through various initiatives. These include:

  • Animal Health Research: Zoetis supports research in animal health, including studies on antimicrobial resistance
  • Veterinary Education: The company provides educational programs and resources for veterinarians and veterinary students
  • Community Outreach: Zoetis participates in local community outreach programs to promote animal welfare and public health

Zoetis’ Business Operations

Zoetis operates globally with manufacturing facilities, research centers, and sales offices in over 100 countries. The company’s business operations are divided into two main segments:

  • United States: Zoetis generates a significant portion of its revenue from the U.S. market
  • International: The company has a strong presence in international markets, particularly in Europe, Asia, and Latin America

Zoetis’ Financial Performance

Zoetis has delivered consistently strong financial performance over the years. Key highlights include:

  • Revenue Growth: Revenue growth at 6% CAGR from 2018 to 2023
  • Net Income: Net income of $1.5 billion in 2023, up from $1.2 billion in 2022
  • Cash Flow Generation: Cash flow from operations of $2.5 billion in 2023, up from $2.2 billion in 2022

Zoetis’ Strategic Priorities

Zoetis has identified several strategic priorities to drive growth and improve profitability:

  • Innovation: The company is investing heavily in research and development to create new products and services
  • Digitalization: Zoetis is implementing digital technologies, such as AI and data analytics, to improve operational efficiency and customer engagement
  • Sustainability: The company is committed to reducing its environmental impact through various sustainability initiatives

Investor Relations

For investor-related inquiries or to submit questions for the webcast and conference call, please contact:

Steve Frank (973) 822-7141 (o)
Nick Soonthornchai (973) 443-2792 (o)

Media Relations

For media-related inquiries or to schedule an interview with a Zoetis spokesperson, please contact:

Jennifer Albano (862) 399-0810 (o)
Laura Panza (973) 975-5176 (o)

View Source Version on Businesswire.com

To view the source version of this press release, please visit https://www.businesswire.com/news/home/20250107897475/en/.